Indeed, among meningiomas that had undergone WGS, every meningioma with loss of chromosome 22 exhibited inactivation of NF2. In four cases (27%), this inactivation was due to truncating rearrangements that may not be detectable by targeted sequencing. The gene discussed is NF2; the disease is meningioma.